The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
KSQ Therapeutics + CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapies for the Treatment of Solid Tumors
Lexington, Mass., September 6, 2023 — KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its...
CTMC MARKS ONE YEAR OF ACCELERATING LIFE-SAVING CELL THERAPIES TO PATIENTS
Leading Cell Therapy Developer to Attend BIO in Boston, June 5-8 HOUSTON (June 5, 2023) — CTMC, a joint venture between MD Anderson Cancer Center...
Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
HOUSTON, Texas, Dec 19, 2022 – Invectys, Inc. and CTMC, a joint venture between MD Anderson Cancer Center and National Resilience, Inc., today...
Recent News
Opinion: To Scale Cell Therapy, Regional Manufacturing Is the Smart Middle Path
By Jane Koo The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between...
Navigating cell therapy’s maze of risks
How a strategic, collaborative approach can accelerate product development and bring cell therapies to patients Jason Bock, Ph.D. Access the...
San Jac interns set standard for biomanufacturing collaboration
Jacquelynn Conger PASADENA, Texas – A transformative partnership between San Jacinto College and CTMC is producing powerful...
What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?
Pharma's Almanac / PAO-09-25-NI-01 Access the article: Pharma's Almanac
HealthBiz Podcast: Delivering on the Promise of CAR T Cell Therapy w/ Dr. Jason Bock
Access the podcast: HealthBiz with David Williams
APAC is dynamic and rapidly evolving, with tremendous growth in R&D and attractive market conditions
| Opinion | By Dr Manbeena Chawla With cell and gene therapy (CGT) representing a major advancement in medical...
Inside CTMC: Innovating cell therapy development from patient to clinic
Cell therapy has emerged as one of the most promising frontiers in biopharmaceutical innovation, offering potential cures for diseases once...
Houston’s Biotech Ecosystem: The Ideal Launchpad for Life Sciences Startups
Access Greater Houston Partnership's blog: GHP
CAR T-Cell Therapy: New Advances Move On Past Setbacks
Ongoing efforts to go from “liquid” to “solid” tissues are starting to pay off in multiple diseases Access the article: GEN news